Authors:
de Gast, GC
Klumpen, HJ
Vyth-Dreese, FA
Kersten, MJ
Verra, NCV
Sein, J
Batchelor, D
Nooijen, WJ
Schornagel, JH
Citation: Gc. De Gast et al., Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma, CLIN CANC R, 6(4), 2000, pp. 1267-1272
Authors:
van Baarle, D
Hovenkamp, E
Dukers, NHTM
Renwick, N
Kersten, MJ
Goudsmit, J
Coutinho, RA
Miedema, F
van Oers, MHJ
Citation: D. Van Baarle et al., High prevalence of Epstein-Barr virus type 2 among homosexual men is caused by sexual transmission, J INFEC DIS, 181(6), 2000, pp. 2045-2049
Authors:
Berger, C
van Baarle, D
Kersten, MJ
Klein, MR
Al-Homsi, AS
Dunn, B
McQuain, C
van Oers, R
Knecht, H
Citation: C. Berger et al., Carboxy terminal variants of Epstein-Barr virus-encoded latent membrane protein 1 during long-term human immunodeficiency virus infection: Reliable markers for individual strain identification, J INFEC DIS, 179(1), 1999, pp. 240-244
Authors:
van Baarle, D
Hovenkamp, E
Kersten, MJ
Klein, MR
Miedema, F
van Oers, MHJ
Citation: D. Van Baarle et al., Direct Epstein-Barr virus (EBV) typing on peripheral blood mononuclear cells: No association between EBV type 2 infection or superinfection and the development of acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma, BLOOD, 93(11), 1999, pp. 3949-3955